dEEGtal

🚀 dEEGtal is heading to Breckenridge, Colorado, for the AI in Epilepsy conference! We’re excited to join this incredible community of researchers, clinicians, and innovators exploring how AI is transforming epilepsy diagnosis and treatment. At dEEGtal, we’re pushing the boundaries of AI-powered EEG analysis to make epilepsy diagnosis faster, more precise, and more accessible. Are you attending the conference? Let’s connect! Whether you’re working on EEG, AI in neurology, or epilepsy research, we’d love to exchange ideas, discuss potential collaborations, and explore how we can advance the field together. Drop us a message and let’s grab a coffee—we look forward to meeting you in Breckenridge! #AIinEpilepsy #EpilepsyResearch #EEG #AIinHealthcare #Neurotech #dEEGtal #LetsConnect

Exciting initiative from Microsoft! At dEEGtal, we’re looking forward to participating in the AI Tour and exploring how cutting-edge AI solutions can transform healthcare. Innovation in AI-driven EEG analysis is at the heart of what we do, and we’re eager to connect with experts and industry leaders to push the boundaries even further. See you there! #AI #HealthcareInnovation #dEEGtal

🌍🚀 €200 Billion for AI in Europe – A Game-Changer! The EU just launched InvestAI, a historic €200 billion initiative to establish Europe as a global leader in AI. Beyond industrial applications, this bold move could revolutionize fields like healthcare, with advanced infrastructure and ethical AI development at its core. For companies like dEEGtal working on AI-powered solutions for epilepsy diagnosis, this investment could provide critical support to scale innovation and improve lives. 🎯 Highlights: • AI Factories & GigaFactories • 12 cutting-edge AI hubs with EuroHPC supercomputers • Open access to world-class AI infrastructure Could this be the tipping point for Europe’s AI ecosystem? The future just got more exciting. #AI #HealthcareInnovation #InvestAI #Europe #dEEGtal

🤝 dEEGtal is proud to be part of this incredible alliance between the Wyss Center for Bio and Neuroengineering , The Moody Brain Health Institute at The University of Texas Medical Branch working together to advance neurological technologies and improve patient outcomes. 🧠 This collaboration bridges scientific, engineering, and entrepreneurial expertise to tackle some of the most pressing challenges in #neurological and #mentalhealth disorders. 🌟 A heartfelt thank you to the Wyss Center for hosting this inspiring meeting in #Geneva and to The University of Texas Medical Branch for their invaluable support. It was a privilege to share ideas alongside brilliant colleagues from The University of Texas Medical Branch, Rice University, and fellow startups—Clee Medical, ABILITY Neurotech, Dandelion Science, Neurosoft Bioelectronics, and AngelWave Medical. Together, we’re shaping a new era in neuroscience research and driving innovation to improve lives. #Innovation #Neurotechnology #Collaboration #PatientCare #NeurologicalDisorders

🎉 It’s now official! 🎉 We are proud to announce that with a CHF 750,000 investment from the Wyss Center for Bio and Neuroengineering, dEEGtal has successfully closed its seed funding round of CHF 1 million! 🚀 As a spin-off of Geneva University Hospitals and the University of Geneva, dEEGtal is revolutionizing epilepsy diagnostics. This funding milestone reflects a shared commitment to advancing patient care through innovation. As Erwin Böttinger, Director of the Wyss Center, noted: “dEEGtal Insight represents a major step forward in epilepsy detection, and we are proud to support this innovation.” With this incredible support, we are ready to take the next steps in bringing our technology to clinicians worldwide, ensuring faster and more reliable diagnoses for millions of patients. 🔗 Learn more: www.deegtal.ai 💡 Interested in partnering with us? Let’s connect! 📣 Press release: https://lnkd.in/d6tsgE9a Together, we are shaping the future of healthcare. 🌟 #HealthTech #Epilepsy #AI #Innovation #FundingSuccess #PatientCare

🧠💡 "Think of an AI algorithm like an ICU patient—it needs to be monitored constantly." – FDA Commissioner Robert Califf, MD https://lnkd.in/dj6qD59s This perspective resonates deeply as we develop AI solutions for EEG and epilepsy diagnostics at dEEGtal. It’s a reminder that innovation in healthcare comes with the responsibility to ensure safety, fairness, and effectiveness. We’re learning and growing every day, and we believe collaboration across the healthcare ecosystem is essential to achieving meaningful progress. What are your thoughts on how AI can be responsibly integrated into healthcare? #HealthcareAI #Innovation #dEEGtal #AIRegulation #Collaboration

We’re excited to share that dEEGtal has been awarded CHF 40,000 at Venture Kick’s second stage of support! 🎉 At dEEGtal, we’re developing AI-powered software to help clinicians analyze EEG data more efficiently and accurately. Our goal is to support earlier and more reliable epilepsy diagnosis, improving outcomes for patients worldwide. A big thank you to Venture Kick for believing in our mission, and congratulations to the other inspiring startups in this cohort. Together, we’re making strides in innovation and healthcare. Read more here: https://lnkd.in/d8JsjWCn #VentureKick #SwissStartups #EpilepsyAwareness #AIinHealthcare

🚀 Exciting News from dEEGtal! 🚀   We are thrilled to welcome our new Lead AI Engineer, Soheil Rayatdoost, to the dEEGtal family! Soheil brings a wealth of expertise to our team, having developed deep learning models for medtech applications and conducted pioneering work with EEG data during his PhD.   His impressive background and passion for leveraging AI in healthcare make him a perfect fit for dEEGtal’s mission to enhance early epilepsy detection. We’re confident that his skills will be instrumental in designing and refining our cutting-edge AI models.   Join us in giving Soheil a warm welcome! We’re looking forward to a future of groundbreaking innovations together.   #TeamGrowth #dEEGtal #AIInHealthcare #EpilepsyAwareness

🟣 November is #EpilepsyAwarenessMonth, a time dedicated to increasing public understanding of epilepsy and dispelling the myths that surround this neurological condition. 🧠⚡ As we step into this important month, let’s reflect on the challenges faced by over 50 million people worldwide living with epilepsy. Awareness is more than just knowledge; it's about fostering empathy, improving patient care, and driving research towards innovative treatments. At dEEGtal, we're committed to pushing the boundaries of medical technology by developing AI-driven tools that enhance the accuracy of epilepsy diagnostics through advanced EEG analysis. This month, we recommit ourselves to making a tangible difference in the lives of those affected by epilepsy. Join us in spreading the word and supporting epilepsy education. Together, we can illuminate the path to a more understanding and supportive society. #EpilepsyAwareness #Neurology #AI #HealthTech #dEEGtal

Attention Neurology Professionals! 🧠 At dEEGtal, we're dedicated to advancing the field of neurology through innovative AI-driven solutions. As part of our commitment, we're conducting a survey to gather insights directly from experts like you. Your knowledge and experience are invaluable to us! 👩⚕️👨⚕️ Why participate? - Help shape the future of epilepsy diagnostics. - Contribute to the development of technology that could change patient outcomes. It only takes 5 minutes, and your feedback will have a lasting impact. Please check out https://lnkd.in/g8H6rkBZ to complete the survey. We appreciate your time and expertise, and we're excited to see how your input can lead to breakthroughs in the care we provide. Thank you for joining us in this important endeavor!